Search results
Salesforce launches Life Sciences Cloud for organizing clinical trials and patient outreach -...
SiliconANGLE· 5 days agoThe Salesforce Life Sciences Cloud platform is generally available today and comes with a heavy dose...
Shareholders in Gilead Sciences (NASDAQ:GILD) are in the red if they invested a year ago
Simply Wall St. via Yahoo Finance· 4 days agoIf the fundamental data continues to indicate long term sustainable growth, the current sell-off...
ASCO 2024: How to Best Use New Breast Cancer Data
Medscape· 3 days agoKevin Kalinsky and Sara Hurvitz discuss the results of awaited data in the breast cancer space presented at the 2024 ASCO Annual Meeting.
From AI trainers to ethicists: AI may obsolete some jobs but generate new ones
ZDNet· 6 days agoA job ad appeared recently for an "AI competency leader," which was a role that involved,...
Kobach sues Pfizer over COVID vaccine claims
KSNW Wichita via Yahoo News· 6 days agoKansas Attorney General Kris Kobach has filed a lawsuit against Pfizer. He says the company made misleading and deceptive claims about its COVID-19...
They started high school in COVID-19. Now they're ending it in-person. Here's what they've learned
Detroit Free Press via Yahoo News· 6 days agoI'm going to be getting my bachelor's of science in neuroscience. I recently was reading a bunch of...
AI skills or AI-enhanced skills? What employers need could depend on you
ZDNet· 6 days agoThe new types of jobs that are emerging around artificial intelligence aren't necessarily the...
We're in a post-truth world now. So, how can we escape the mass delusions?
Fox News· 1 day agoNEWYou can now listen to Fox News articles! At some point during the COVID-19 pandemic, we stopped...
Israeli women rush to buy guns in October 7 aftermath
AFP via Yahoo News· 1 day agoWith many Israelis gripped by a sense of insecurity following Hamas's unprecedented October 7...
Vertical Software Stocks Q1 Highlights: 2U (NASDAQ:TWOU)
StockStory via Yahoo Finance· 2 days agoAs the Q1 earnings season wraps, let's dig into this quarter's best and worst performers in the...